Leonard Freedman, founding president of the Global Biological Standards Institute, has been appointed chief science officer at a federally-funded research and development center Leidos manages for the National Cancer Institute.
He will oversee internal scientific programs at the Frederick National Laboratory for Cancer Research and its external collaborative efforts in the science and technology area, FNLCR said Thursday.
Ethan Dmitrovsky, director of FNLCR and president of Leidos’ biomedical research subsidiary, said Freedman brings biomedical research, science policy and drug discovery experience to his new position.
His industry career has included leadership positions at pharmaceutical companies Wyeth and Merck. He previously served as a professor at Thomas Jefferson University’s Jefferson Medical College, Memorial Sloan-Kettering Cancer Center and Weil Cornell Medical College.
Freedman is a recipient of the National Institutes of Health‘s MERIT award and the Endocrine Society’s Ernst Oppenheimer Award.